Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 1
2011 5
2012 8
2013 5
2014 6
2015 7
2016 8
2017 4
2018 2
2020 7
2021 14
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial.
Schoser B, Roberts M, Byrne BJ, Sitaraman S, Jiang H, Laforêt P, Toscano A, Castelli J, Díaz-Manera J, Goldman M, van der Ploeg AT, Bratkovic D, Kuchipudi S, Mozaffar T, Kishnani PS; PROPEL Study Group. Schoser B, et al. Lancet Neurol. 2021 Dec;20(12):1027-1037. doi: 10.1016/S1474-4422(21)00331-8. Lancet Neurol. 2021. PMID: 34800400 Clinical Trial.
[Personalized treatment options for spinal muscular atrophy].
Szabó-Taylor K, Molnár JM. Szabó-Taylor K, et al. Among authors: molnar jm. Ideggyogy Sz. 2023 Mar 30;76(3-4):77-94. doi: 10.18071/isz.76.0077. Ideggyogy Sz. 2023. PMID: 37009768 Free article. Review. Hungarian.
Solving unsolved rare neurological diseases-a Solve-RD viewpoint.
Schüle R, Timmann D, Erasmus CE, Reichbauer J, Wayand M; Solve-RD-DITF-RND; van de Warrenburg B, Schöls L, Wilke C, Bevot A, Zuchner S, Beltran S, Laurie S, Matalonga L, Graessner H, Synofzik M; Solve-RD Consortium. Schüle R, et al. Eur J Hum Genet. 2021 Sep;29(9):1332-1336. doi: 10.1038/s41431-021-00901-1. Epub 2021 May 10. Eur J Hum Genet. 2021. PMID: 33972714 Free PMC article. No abstract available.
Gender issues during the times of COVID-19 pandemic.
Grisold W, Moro E, Teresa Ferretti M, Hege Aamodt A, Arabia G, Lebedeva ER, Carvalho V, Rakusa M, Vonck K, Aybeck S, Hassan Mansour A, Goudier R, Giovannoni G, Jaarsma J, Judit Molnar M, Matczack M, Bassetti C, de Visser M; EAN Gender, Diversity Issues Task Force. Grisold W, et al. Among authors: judit molnar m. Eur J Neurol. 2021 Oct;28(10):e73-e77. doi: 10.1111/ene.14815. Epub 2021 Jun 25. Eur J Neurol. 2021. PMID: 33751757 Free PMC article. No abstract available.
Rare and Complex Urology: Clinical Overview of ERN eUROGEN.
Oomen L, Leijte E, Shilhan DE, Battye M; Members of ERN eUROGEN; Feitz WFJ. Oomen L, et al. Eur Urol. 2022 Feb;81(2):204-212. doi: 10.1016/j.eururo.2021.02.043. Epub 2021 Mar 18. Eur Urol. 2022. PMID: 33743996 Free article.
Correction: Solving unsolved rare neurological diseases-a Solve-RD viewpoint.
Schüle R, Timmann D, Erasmus CE, Reichbauer J, Wayand M; Solve-RD-DITF-RND; van de Warrenburg B, Schöls L, Wilke C, Bevot A, Zuchner S, Beltran S, Laurie S, Matalonga L, Graessner H, Synofzik M; Solve-RD Consortium. Schüle R, et al. Eur J Hum Genet. 2021 Sep;29(9):1462-1465. doi: 10.1038/s41431-021-00935-5. Eur J Hum Genet. 2021. PMID: 34429526 Free PMC article. No abstract available.
66 results